Skip to main content

Market Overview

ISI Group Initiates Core Laboratories With Buy

Share:

Analysts at ISI Group initiated coverage on Core Laboratories N.V. (NYSE: CLB) with a Buy rating.

The target price for Core Laboratories is set to $151.

Core Laboratories shares have declined 27.02% over the past 52 weeks, while the S&P 500 index has surged 7.46% in the same period.

Core Laboratories' shares gained 3.63% to close at $138.56 yesterday.

Latest Ratings for CLB

DateFirmActionFromTo
Jan 2022Morgan StanleyMaintainsEqual-Weight
Dec 2021Morgan StanleyMaintainsEqual-Weight
Oct 2021B of A SecuritiesDowngradesNeutralUnderperform

View More Analyst Ratings for CLB

View the Latest Analyst Ratings

 

Related Articles (CLB)

View Comments and Join the Discussion!

Posted-In: ISI GroupInitiation Analyst Ratings

Latest Ratings

StockFirmActionPT
SEDGB of A SecuritiesMaintains411.0
PTLOPiper SandlerMaintains28.0
AOUTLake StreetMaintains26.0
RAPTPiper SandlerMaintains52.0
OCXLake StreetMaintains6.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com